Literature DB >> 26152285

Interaction between microRNA-181a and TNFAIP1 regulates pancreatic cancer proliferation and migration.

Peng Zhang1, Zhiyong Guo1, Ronglin Hu1, Xiaoshun He1, Xingyuan Jiao2, Xiaofeng Zhu3.   

Abstract

We investigated the role of microRNA 181a (miR-181a) and its downstream target tumor necrosis factor, alpha-induced protein 1 (TNFAIP1) in pancreatic cancer regulation. Quantitative real-time PCR (qRT-PCR) was applied to evaluate the gene expression of miR-181a in seven pancreatic cancer cell lines. MiR-181a inhibitor lentivirus (miR-181a-IN) was used to down-regulate miR-181a in Capan-1 and AsPC-1 cells. The effects of miR-181a down-regulation on pancreatic cancer were evaluated by in vitro proliferation assay and migration assay. Targeting of miR-181a on TNFAIP1 in pancreatic cancer was evaluated by dual-luciferase reporter assay and western blot. TNFAIP1 was either upregulated by pcDNA3.1 (+) expression vector or down-regulated by siRNA in Capan-1 and AsPC-1 cells. The subsequent effects of TNFAIP1 upregulation or down-regulation on miR-181a mediated pancreatic cancer regulation were also evaluated through in vitro proliferation and migration assays. The in vivo effect of miR-181a down-regulation on pancreatic tumor growth was evaluated by a xenograft assay. MiR-181a was consistently upregulated in pancreatic cancer cell lines. MiR-181a down-regulation inhibited proliferation and migration in vitro, and upregulated TNFAIP1 in pancreatic cancer cells. Ectopic TNFAIP1 overexpression had similar tumor-suppressive effects on pancreatic cancer proliferation and migration as miR-181a down-regulation, whereas siRNA-mediated TNFAIP1 down-regulation had opposite or oncogenic effects on pancreatic cancer. In vivo pancreatic xenograft showed miR-181a recapitulated the in vitro anti-tumor effects and its regulation on TNFAIP1. MiR-181a played a critical role in regulating pancreatic cancer growth and migration, likely interacting with TNFAIP1.

Entities:  

Keywords:  Migration; Pancreatic cancer; TNFAIP1; Tumor proliferation; miR-181a

Mesh:

Substances:

Year:  2015        PMID: 26152285     DOI: 10.1007/s13277-015-3704-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  23 in total

1.  MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients.

Authors:  O Slaby; R Lakomy; P Fadrus; R Hrstka; L Kren; E Lzicarova; M Smrcka; M Svoboda; H Dolezalova; J Novakova; D Valik; R Vyzula; J Michalek
Journal:  Neoplasma       Date:  2010       Impact factor: 2.575

2.  Expression profiling identifies microRNA signature in pancreatic cancer.

Authors:  Eun Joo Lee; Yuriy Gusev; Jinmai Jiang; Gerard J Nuovo; Megan R Lerner; Wendy L Frankel; Daniel L Morgan; Russell G Postier; Daniel J Brackett; Thomas D Schmittgen
Journal:  Int J Cancer       Date:  2007-03-01       Impact factor: 7.396

3.  Decreased serum miR-181a is a potential new tool for breast cancer screening.

Authors:  Li-Juan Guo; Qing-Yun Zhang
Journal:  Int J Mol Med       Date:  2012-06-11       Impact factor: 4.101

4.  MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.

Authors:  Mark Bloomston; Wendy L Frankel; Fabio Petrocca; Stefano Volinia; Hansjuerg Alder; John P Hagan; Chang-Gong Liu; Darshna Bhatt; Cristian Taccioli; Carlo M Croce
Journal:  JAMA       Date:  2007-05-02       Impact factor: 56.272

5.  microRNA-372 maintains oncogene characteristics by targeting TNFAIP1 and affects NFκB signaling in human gastric carcinoma cells.

Authors:  Chang Zhou; Xiaofeng Li; Xiaoting Zhang; Xizhi Liu; Zhiwen Tan; Celi Yang; Jian Zhang
Journal:  Int J Oncol       Date:  2012-12-13       Impact factor: 5.650

6.  Knockdown of TNFAIP1 inhibits growth and induces apoptosis in osteosarcoma cells through inhibition of the nuclear factor-κB pathway.

Authors:  Cheng-Lin Zhang; Ce Wang; Wang-Jun Yan; Rui Gao; Yong-Hua Li; Xu-Hui Zhou
Journal:  Oncol Rep       Date:  2014-06-25       Impact factor: 3.906

Review 7.  Pancreatic cancer today.

Authors:  Michael C Safioleas; Konstantinos G Moulakakis
Journal:  Hepatogastroenterology       Date:  2004 May-Jun

Review 8.  Tumour necrosis factor and cancer.

Authors:  Frances Balkwill
Journal:  Nat Rev Cancer       Date:  2009-04-03       Impact factor: 60.716

Review 9.  TNF: a master switch for inflammation to cancer.

Authors:  Gautam Sethi; Bokyung Sung; Bharat B Aggarwal
Journal:  Front Biosci       Date:  2008-05-01

Review 10.  MicroRNAs as potential biomarkers in cancer: opportunities and challenges.

Authors:  Huiyin Lan; Haiqi Lu; Xian Wang; Hongchuan Jin
Journal:  Biomed Res Int       Date:  2015-03-22       Impact factor: 3.411

View more
  9 in total

1.  miR-181a-2 downregulates the E3 ubiquitin ligase CUL4A transcript and promotes cell proliferation.

Authors:  Venkateshwarlu Bandi; Sudhakar Baluchamy
Journal:  Med Oncol       Date:  2017-07-20       Impact factor: 3.064

2.  Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation.

Authors:  Andrea E Calvert; Alexandra Chalastanis; Yongfei Wu; Lisa A Hurley; Fotini M Kouri; Yingtao Bi; Maureen Kachman; Jasmine L May; Elizabeth Bartom; Youjia Hua; Rama K Mishra; Gary E Schiltz; Oleksii Dubrovskyi; Andrew P Mazar; Marcus E Peter; Hongwu Zheng; C David James; Charles F Burant; Navdeep S Chandel; Ramana V Davuluri; Craig Horbinski; Alexander H Stegh
Journal:  Cell Rep       Date:  2017-05-30       Impact factor: 9.423

Review 3.  MicroRNA in pancreatic cancer.

Authors:  Keiichi Yonemori; Hiroshi Kurahara; Kosei Maemura; Shoji Natsugoe
Journal:  J Hum Genet       Date:  2016-06-02       Impact factor: 3.172

Review 4.  The emerging role of the KCTD proteins in cancer.

Authors:  Annapaola Angrisani; Annamaria Di Fiore; Enrico De Smaele; Marta Moretti
Journal:  Cell Commun Signal       Date:  2021-05-17       Impact factor: 5.712

5.  miR-181a modulates proliferation, migration and autophagy in AGS gastric cancer cells and downregulates MTMR3.

Authors:  Yong Lin; Jing Zhao; Hong Wang; Jie Cao; Yuqiang Nie
Journal:  Mol Med Rep       Date:  2017-03-07       Impact factor: 2.952

6.  The expression and role of miR-181a in multiple myeloma.

Authors:  Ruili Yuan; Ni Liu; Jinyu Yang; Jing Peng; Lina Liu; Xuan Guo
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

7.  MiRNA-Mediated Subpathway Identification and Network Module Analysis to Reveal Prognostic Markers in Human Pancreatic Cancer.

Authors:  Yuejuan Liu; Yuxia Cui; Xuefeng Bai; Chenchen Feng; Meng Li; Xiaole Han; Bo Ai; Jian Zhang; Xuecang Li; Junwei Han; Jiang Zhu; Yong Jiang; Qi Pan; Fan Wang; Mingcong Xu; Chunquan Li; Qiuyu Wang
Journal:  Front Genet       Date:  2020-12-09       Impact factor: 4.599

Review 8.  Regulation of microRNAs function by circular RNAs in human cancer.

Authors:  Chao Han; Nicole A Seebacher; Francis J Hornicek; Quancheng Kan; Zhenfeng Duan
Journal:  Oncotarget       Date:  2017-08-04

9.  Evaluation of polymorphisms in microRNA-binding sites and pancreatic cancer risk in Chinese population.

Authors:  Juntao Ke; Xiating Peng; Shufang Mei; Jianbo Tian; Pingting Ying; Nan Yang; Xiaoyang Wang; Danyi Zou; Yang Yang; Ying Zhu; Yajie Gong; Jing Gong; Rong Zhong; Jiang Chang; Zemin Fang; Xiaoping Miao
Journal:  J Cell Mol Med       Date:  2019-12-27       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.